ストックスクリーナーアプリを入手
0.8301
8.28%
-0.0749
アフターアワーズ：
.82
-0.0101
-1.22%
前日終値:
$0.905
開ける：
$0.9498
24時間の取引高:
77,100
Relative Volume:
0.44
時価総額：
$37.16M
収益：
$80.28M
当期純損益:
$-38.83M
株価収益率:
-0.998
EPS:
-0.8318
ネットキャッシュフロー:
$-28.67M
1週間 パフォーマンス:
-14.43%
1か月 パフォーマンス:
+21.57%
6か月 パフォーマンス:
-29.65%
1年 パフォーマンス:
-24.54%
1日の値動き範囲:
$0.83
$0.9598
1週間の範囲:
$0.83
$1.16
52週間の値動き範囲:
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.8301 | 40.51M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
87.91 | 147.13B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.22 | 117.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.32 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.92 | 78.30B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.39 | 46.86B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Tela Bio Inc (TELA) 最新ニュース
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us - FinancialContent
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Becton Hernia Mesh Antitrust Case Survives Dismissal - Law360
TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens - Stock Titan
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M - MSN
Q1 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio revenue up 3% to USD 19.1M in Q1 2026 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2026 Earnings Call Transcript - Insider Monkey
TELA Bio, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong Eur - GuruFocus
TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript Summary - Moomoo
Is TELA Bio (TELA) a Possible Value Trap After Q1 2026? EPS Not - GuruFocus
TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA - Moomoo
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip By Investing.com - Investing.com South Africa
Tela Bio earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip - Investing.com Australia
TELA Bio Q1 2026 Earnings Call Transcript - Benzinga
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
TELA Bio posts modest Q1 growth, maintains 2026 outlook - TipRanks
TELA Bio (NASDAQ:TELA) Reports Mixed Q1 Results with Revenue Beat but Wider Loss and Cautious Q2 Guidance - ChartMill
TELA Bio Reports First Quarter 2026 Financial Results - The Manila Times
TELA Bio Q1 revenue growth beats estimates, loss widens - TradingView
TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TELA Bio, Inc. Provides Revenue Guidance for the Second Quarter 2026 and Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings - GuruFocus
TELA Q1'26 Earnings: EPS estimate is (0.18) USD - TradingView
TELA Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Why TELA Bio (TELA) could be the turning point you've been waiting for (Moonwalks) 2026-05-08Buy Signals - newser.com
TELA Bio (TELA) shares surge 11% after beating Q4 earnings estimates, defying analyst pessimism.Earnings Risk - newser.com
Earnings Preview: TELA Bio to Report Financial Results Post-market on May 12 - Moomoo
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat - MyChesCo
TELA Bio (TELA) posts narrower than expected Q4 2025 loss, sending shares up 4.59 percent in today’s trading.Convertible Notes - newser.com
LIQUIFIX offers new approach to mesh fixation, TELA Bio claims - Traders Union
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), TELA Bio (TELA) and Nanobiotix (NBTX) - The Globe and Mail
TELA Bio Reshapes Board, Appoints New Chairman, Directors - The Globe and Mail
12 Health Care Stocks Moving In Friday's After-Market SessionAkanda (NASDAQ:AKAN), BioVie (NASDAQ:BIVI - Benzinga
What's Driving TELA Bio's Board Refreshment and Strategic Shift - Kavout
Lake Street Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Piper Sandler Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
$19M Q1 tops TELA Bio outlook as 4 new directors join - Stock Titan
TELA Bio Taps Turnaround Titans for Board in Bold Push for Profitability - BriefGlance
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
1.72%
大文字化:
|
ボリューム (24 時間):